Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Eradia 125 mg/ml V/DCP/18/0007 VIRBAC, Francija QP51AA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release DELPHARM Huningue, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0007-01 1 PET pudele ar atvāžamu vāciņu, 30 ml -
V/DCP/18/0007-02 1 PET pudele ar atvāžamu vāciņu, 100 ml -
V/DCP/18/0007-03 1 PET pudele ar skrūvējamu vāciņu, 30 ml -
V/DCP/18/0007-04 1 PET pudele ar skrūvējamu vāciņu, 100 ml -
Excenel Evo 50 mg/ml V/MRP/11/0055 Zoetis Belgium S.A., Beļģija QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur (as ceftiofur hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 04-Oct-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Summary of product characteristics: [PDF] Zāļu_informācija_ZA_M_LI (22-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/11/0055-01 50 mg/ml 1 Stikla pudelīte, 50 ml -
V/MRP/11/0055-02 50 mg/ml 10 Stikla pudelīte, 50 ml -
V/MRP/11/0055-03 50 mg/ml 1 Stikla pudelīte, 100 ml -
V/MRP/11/0055-04 50 mg/ml 10 Stikla pudelīte, 100 ml -
V/MRP/11/0055-05 50 mg/ml 1 Stikla flakons, 250 ml -
Pulmovet 250 mg/ml V/DCP/18/0030 Dopharma Research B.V., Nīderlande QJ01FA91 cattle; pigs; turkeys; chickens Vairāk

Medicinal product information

Pharmaceutical form: solution for use in drinking water or milk replacer
International name (active substance): Tilmicosin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Oct-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Oct-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Jul-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0030-01 1 ABPE pudele, 960 ml -
V/DCP/18/0030-02 1 Polietilēna kanna, 5040 ml -
EFFIPRO 402 mg/pipetē V/DCP/22/0033 Virbac S.A., Francija QP53AX15 very large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 26-Jul-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0033-01 402 mg/pipetē 1 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-02 402 mg/pipetē 2 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-03 402 mg/pipetē 3 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-04 402 mg/pipetē 4 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-05 402 mg/pipetē 6 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-06 402 mg/pipetē 8 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-07 402 mg/pipetē 12 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-08 402 mg/pipetē 24 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-09 402 mg/pipetē 30 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-10 402 mg/pipetē 60 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-11 402 mg/pipetē 90 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-12 402 mg/pipetē 150 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-13 402 mg/pipetē 1 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-14 402 mg/pipetē 2 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-15 402 mg/pipetē 3 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-16 402 mg/pipetē 4 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-17 402 mg/pipetē 6 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-18 402 mg/pipetē 8 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-19 402 mg/pipetē 12 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-20 402 mg/pipetē 24 Termoformēta pipete, 4,02 ml -
Thyroxanil vet 200 µg V/DCP/16/0010 Le Vet Beheer B.V., Nīderlande QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lindopharm GmbH, Vācija;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 24-Feb-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 300316LI (24-Feb-2021)
Labelling text: [DOCX] 300316M (24-Feb-2021)
Summary of product characteristics: [DOCX] 300316ZA (24-Feb-2021)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0010-01 200 µg 1 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-02 200 µg 2 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-03 200 µg 3 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-04 200 µg 4 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-05 200 µg 5 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-06 200 µg 6 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-07 200 µg 7 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-08 200 µg 8 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-09 200 µg 9 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-10 200 µg 10 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-11 200 µg 1 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-12 200 µg 2 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-13 200 µg 3 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-14 200 µg 4 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-15 200 µg 5 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-16 200 µg 6 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-17 200 µg 7 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-18 200 µg 8 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-19 200 µg 9 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-20 200 µg 10 Aclar/PVH blisteris, 30 tablete -
Thyroxanil vet 600 µg V/DCP/16/0011 Le Vet Beheer B.V., Nīderlande QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lindopharm GmbH, Vācija;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 24-Feb-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 300316LI (24-Feb-2021)
Labelling text: [DOCX] 300316M (24-Feb-2021)
Summary of product characteristics: [DOCX] 300316ZA (24-Feb-2021)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0011-01 600 µg 1 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-02 600 µg 2 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-03 600 µg 3 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-04 600 µg 4 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-05 600 µg 5 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-06 600 µg 6 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-07 600 µg 7 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-08 600 µg 8 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-09 600 µg 9 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-10 600 µg 10 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-11 600 µg 1 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-12 600 µg 2 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-13 600 µg 3 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-14 600 µg 4 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-15 600 µg 5 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-16 600 µg 6 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-17 600 µg 7 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-18 600 µg 8 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-19 600 µg 9 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-20 600 µg 10 Aclar/PVH blisteris, 30 tablete -
Vetmedin 2.5 mg V/DCP/11/0011 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Meda Manufacturing GmbH, Vācija;Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 21-Mar-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0011-01 2,5 mg 1 Polipropilēna flakons, 50 tablete -
Vetmedin 5 mg V/DCP/11/0012 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Meda Manufacturing GmbH, Vācija;Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 21-Mar-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0012-01 5 mg 1 Polipropilēna flakons, 50 tablete -
Nalgosed 10 mg/ml V/MRP/18/0021 Bioveta, a.s., Čehija QN02AF01 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Butorphanol
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 21-May-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 210521LI (21-May-2021)
Labelling text: [DOCX] 210521M (21-May-2021)
Summary of product characteristics: [DOCX] 30072024ZA (30-Jul-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0021-01 1 Stikla flakons, 10 ml -
BioBos IBR marker inact. - V/MRP/14/0003 Bioveta, a.s., Čehija QI02AA03 cattle Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated Bovine herpesvirus type 1 (BHV-1), strain Bio-27
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 02-Feb-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0003-01 10 Stikla flakons, 5 deva -
V/MRP/14/0003-02 1 Stikla flakons, 5 deva -
V/MRP/14/0003-03 1 Stikla flakons, 25 deva -
V/MRP/14/0003-04 1 Stikla flakons, 50 deva -
V/MRP/14/0003-05 1 ABPE flakons, 50 deva -
V/MRP/14/0003-06 1 ABPE flakons, 25 deva -
Milprazon CHEWABLE 4 mg/10 mg - V/MRP/19/0011 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 small cats; kittens weighing at least 0.5 kg Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 02-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0011-01 4/10 mg 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/MRP/19/0011-02 4/10 mg 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/MRP/19/0011-03 4/10 mg 12 Al/OPA/Al/PVH blisteris, 4 tablete -
Clavaseptin 50 mg - V/MRP/11/0035 Vetoquinol S.A., Francija QJ01CR02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: palatable tablets
International name (active substance): Amoxicillin trihydrate,Clavulanic acid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 31-Oct-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/11/0035-01 1 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-02 2 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-03 5 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-04 10 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-05 12 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-06 15 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-07 20 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-08 25 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-09 30 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-10 40 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-11 50 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-12 60 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-13 75 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-14 100 Alumīnija blisteris, 10 tablete -
HIPRA GUMBORO CW - V/MRP/18/0044 Laboratorios Hipra S.A., Spānija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for use in drinking water
International name (active substance): Live attenuated Infectious Bursal Disease Virus, strain CH/80
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0044-01 1 Stikla flakons, 1000 deva -
V/MRP/18/0044-02 1 Stikla flakons, 5000 deva -
V/MRP/18/0044-03 1 Stikla flakons, 10000 deva -
V/MRP/18/0044-04 10 Stikla flakons, 1000 deva -
V/MRP/18/0044-05 10 Stikla flakons, 5000 deva -
V/MRP/18/0044-06 10 Stikla flakons, 10000 deva -
Metomotyl 2.5 mg/ml V/DCP/14/0036 Le Vet Beheer B.V., Nīderlande QA03FA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Metoclopramide hydrochloride monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 01-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0036-01 2,5 mg/ml 1 Stikla pudele, 5 ml -
V/DCP/14/0036-02 2,5 mg/ml 1 Stikla pudele, 10 ml -
V/DCP/14/0036-03 2,5 mg/ml 1 Stikla pudele, 20 ml -
V/DCP/14/0036-04 2,5 mg/ml 1 Stikla pudele, 25 ml -
V/DCP/14/0036-05 2,5 mg/ml 1 Stikla pudele, 30 ml -
V/DCP/14/0036-06 2,5 mg/ml 1 Stikla pudele, 50 ml -
Metomotyl 5 mg/ml V/DCP/14/0037 Le Vet Beheer B.V., Nīderlande QA03FA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Metoclopramide hydrochloride monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 01-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0037-01 5 mg/ml 1 Stikla flakons, 5 ml -
V/DCP/14/0037-02 5 mg/ml 1 Stikla flakons, 10 ml -
V/DCP/14/0037-03 5 mg/ml 1 Stikla flakons, 20 ml -
V/DCP/14/0037-04 5 mg/ml 1 Stikla flakons, 25 ml -
V/DCP/14/0037-05 5 mg/ml 1 Stikla flakons, 30 ml -
V/DCP/14/0037-06 5 mg/ml 1 Stikla flakons, 50 ml -
Finilac vet 50 µg/ml V/DCP/15/0002 Le Vet Beheer B.V., Nīderlande QG02CB03 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Cabergoline
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dreluso Pharmazeutika Dr. Elten & Sohn, Vācija
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0002-01 50 µg/ml 1 Stikla pudele, 3 ml -
V/DCP/15/0002-02 50 µg/ml 1 Stikla pudele, 10 ml -
V/DCP/15/0002-03 50 µg/ml 1 Stikla pudele, 15 ml -
V/DCP/15/0002-04 50 µg/ml 1 Stikla pudele, 25 ml -
V/DCP/15/0002-05 50 µg/ml 1 Stikla pudele, 50 ml -
TETRAVET LA 200 mg/ml V/NRP/98/0779 Ceva Sante Animale', Francija QJ01AA06 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Oxytetracycline
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale., Francija
Date of authorisation/renewal: 27-Sep-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/98/0779-01 200 mg/ml 1 Plastikāta flakons, 100 ml -
V/NRP/98/0779-02 200 mg/ml 1 Plastikāta flakons, 250 ml -
V/NRP/98/0779-03 200 mg/ml 1 Plastikāta flakons, 50 ml -
V/NRP/98/0779-04 200 mg/ml 1 Plastikāta flakons, 500 ml -
Biocan Novel Puppy - V/DCP/17/0004 Bioveta, a.s., Čehija QI07AD03 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Canine Distemper virus, strain CDV Bio 11/A,Canine Parvovirus Type 2, strain CPV-2b-Bio 12/B
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 27-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0004-01 5 Stikla flakons, 1 deva -
V/DCP/17/0004-02 10 Stikla flakons, 1 deva -
V/DCP/17/0004-03 25 Stikla flakons, 1 deva -
Vetmedin 1.5 mg/ml V/DCP/25/0008 Boehringer Ingelheim Pharma GmbH & Co. KG, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: Oral solution
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0008-01 1 Stikla pudelīte (dzintarkrāsas), 50 ml -
Lidor 20 mg/ml V/DCP/18/0003 VetViva Richter GmbH , Austrija QN01BB02 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Lidocaine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0003-01 20 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/18/0003-02 20 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/18/0003-03 20 mg/ml 1 Stikla flakons, 250 ml -
V/DCP/18/0003-04 20 mg/ml 5 Stikla flakons, 50 ml -
V/DCP/18/0003-05 20 mg/ml 5 Stikla flakons, 100 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy